Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tedizolid phosphate versus comparator for adolescent complicated skin and soft tissue infection
2014-004023-40Phase 3Completed
- Sponsor
- Cubist Pharmaceuticals, Inc.
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tedizolid in skin and soft tissue infections (SSTIs) (2 arms), sponsored by Cubist Pharmaceuticals, Inc. Primary endpoint: Number of subjects with adverse events on tedizolid phosphate and comparator drugs. Started Feb 2015; status: completed.
02
Drugs
tedizolid
03
Conditions
skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on 2014-004023-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004023-40.